Delivery Order SPE2DR25D3009-SPE2DR26FWJA2
- Not listed
- The Defense Logistics Agency awarded a $2,092.18 delivery order contract to AmerisourceBergen Drug Corp for eluryng vaginal rings on January 15, 2026, with an ultimate completion date of January 16, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a leading pharmaceutical distributor that serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,899.20 to AmerisourceBergen Drug Corp for the supply of eluryng vaginal rings. This firm fixed-price delivery order, which was not set-aside, is scheduled for completion by January 28, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for eluryng vaginal rings under a firm fixed price contract valued at $3,199.14. This delivery order was competitively awarded with no set-aside designation and is scheduled for completion by August 21, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location in the same city. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $2,498.22 to AmerisourceBergen Drug Corp for eluryng vaginal rings on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The contract carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,860.27 to AmerisourceBergen Drug Corp for eluryng vaginal rings, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price contract represents a child delivery order issued under a larger vehicle and carries no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ELURYNG VAGINAL RINGS to the U.S. government. The $2,797.56 Firm Fixed Price contract was awarded on April 22, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of April 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for Annovera vaginal rings with a ceiling value of $1,659.66. This firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is scheduled for completion by November 10, 2025. The contract carries no set-aside designation and was awarded...
- On January 8, 2026, the Defense Logistics Agency awarded a delivery order valued at $14,428.02 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings. This firm fixed-price, non-set-aside contract will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of January 9, 2026. The delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc.'s, larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $1...
- Amerisourcebergen Drug Corp has received a $2,240.25 firm fixed price delivery order from the Defense Logistics Agency (DLA) to supply 4562627175 ELURYNG Vaginal Rings. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to DLA Troop Support Medical facilities in support of military treatment programs. Performance will take place at Amerisourcebergen's Conshohocken, Pennsylvania headquarters, with all work completed by October 30, 2023. No set-aside designation...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,253.13 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Annovera vaginal rings. This is a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, to be performed at the contractor's location in Conshohocken, Pennsylvania. The award was not set aside for any particular business category and represents a competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical...
- SPE2DR25D3009Indefinite Delivery Contract
- SPE2DR25D3009-SPE2DR26FWJA2Delivery Order
On January 29, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,151.33 to Amerisourcebergen Drug Corp for the supply of eluryng vaginal rings. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 30, 2026. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. The awardee operates as a subsidiary of Cencora, Inc., which does business as Amerisourcebergen. This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities to support military healthcare programs worldwide. The contract demonstrates Amerisourcebergen's capability to meet federal procurement requirements through open competition and efficiently fulfill critical pharmaceutical needs across multiple therapeutic domains for military treatment facilities and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/28/26 |